GALECTIN THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

12 أبريل 2024 09:45:05 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

11 أبريل 2024 15:48:32 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

10 أبريل 2024 10:53:14 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

09 أبريل 2024 09:50:38 بحسب NetDania Notify

Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis

09 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

08 أبريل 2024 16:13:55 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

05 أبريل 2024 09:46:14 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

04 أبريل 2024 12:26:47 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

03 أبريل 2024 12:18:08 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

02 أبريل 2024 12:37:00 بحسب NetDania Notify

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

29 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

22 مارس 2024 09:45:05 بحسب NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

21 مارس 2024 11:50:02 بحسب NetDania Notify

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

12 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

13 نوفمبر 2023 08:45:52 بحسب Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

13 نوفمبر 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLD

03 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Galectin Therapeutics to Participate in the H.C. Wainwright 7th Annual NASH Investor Conference on October 24, 2023

23 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Galectin Therapeutics Announces Nomination of Dr. Benjamin S. Carson, Sr. to Board of Directors

12 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Galectin Therapeutics Reports the Positive Outcome of the Fourth Data and Safety Monitoring Board Meeting for NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Portal Hypertension Caused by Non-Alcoholic SteatoHepatitis Liver Cirrhosis

03 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire